For the Patient.
- Published in:
- Allergy & Asthma Proceedings, 2018, v. 39, n. 5, p. 398, doi. 10.2500/aap.2013.39.4170
- Publication type:
- Article
Works in Allergy & Asthma Proceedings, 2018, Vol 39, Issue 5
Results: 14
1
2
Abstracts from the Eastern Allergy Conference, May 31-June 3, 2018, Palm Beach, Florida.
- Published in:
- 2018
- Publication type:
- Abstract
3
A 45-year-old man with elevated levels of immunoglobulin A.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
4
Human factors study of a newly approved prefilled syringe of epinephrine for the treatment of anaphylaxis.
- Published in:
- Allergy & Asthma Proceedings, 2018, v. 39, n. 5, p. 389, doi. 10.2500/aap.2018.39.4154
- By:
- Publication type:
- Article
5
Camel's milk allergy.
- Published in:
- Allergy & Asthma Proceedings, 2018, v. 39, n. 5, p. 384, doi. 10.2500/aap.2018.39.4150
- By:
- Publication type:
- Article
6
Improved diagnostic clarity in shrimp allergic non-dustmite sensitized patients.
- Published in:
- Allergy & Asthma Proceedings, 2018, v. 39, n. 5, p. 377, doi. 10.2500/aap.2018.39.4148
- By:
- Publication type:
- Article
7
Factors that predict disease severity in atopic dermatitis: The role of serum basal tryptase.
- Published in:
- Allergy & Asthma Proceedings, 2018, v. 39, n. 5, p. 371, doi. 10.2500/aap.2018.39.4158
- By:
- Publication type:
- Article
8
Subcutaneous C1-esterase inhibitor to prevent hereditary angioedema attacks: Safety findings from the COMPACT trial.
- Published in:
- Allergy & Asthma Proceedings, 2018, v. 39, n. 5, p. 365, doi. 10.2500/aap.2018.39.4164
- By:
- Publication type:
- Article
9
Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks.
- Published in:
- Allergy & Asthma Proceedings, 2018, v. 39, n. 5, p. 359, doi. 10.2500/aap.2018.39.4151
- By:
- Publication type:
- Article
10
Randomized dose-ranging study of a budesonide metereddose inhaler by using co-suspension delivery technology in asthma.
- Published in:
- Allergy & Asthma Proceedings, 2018, v. 39, n. 5, p. 350, doi. 10.2500/aap.2018.39.4155
- By:
- Publication type:
- Article
11
Seasonal variability of exacerbations of severe, uncontrolled eosinophilic asthma and clinical benefits of benralizumab.
- Published in:
- Allergy & Asthma Proceedings, 2018, v. 39, n. 5, p. 345, doi. 10.2500/aap.2018.39.4162
- By:
- Publication type:
- Article
12
Cost impact of monitoring exhaled nitric oxide in asthma management.
- Published in:
- Allergy & Asthma Proceedings, 2018, v. 39, n. 5, p. 338, doi. 10.2500/aap.2018.39.4165
- By:
- Publication type:
- Article
13
Meta-analysis of randomized controlled trials for the efficacy and safety of anti-interleukin-13 therapy with lebrikizumab in patients with uncontrolled asthma.
- Published in:
- Allergy & Asthma Proceedings, 2018, v. 39, n. 5, p. 332, doi. 10.2500/aap.2018.39.4149
- By:
- Publication type:
- Article
14
Hereditary angioedema revisited.
- Published in:
- 2018
- By:
- Publication type:
- Editorial